HRS 2021: GANGLIA-AF Trial

Просмотров: 432   |   Загружено: 3 год.
icon
Radcliffe Cardiology
icon
8
icon
Скачать
iconПодробнее о видео
In this interview, Dr Min-Young Kim (Imperial College Healthcare NHS Trust, London, UK) discusses the results of the GANGLIA-AF Trial, a study that aimed to determine the role of ectopy-triggering ganglionated plexus ablation (ET-GP) in the treatment of Atrial Fibrillation.

Questions:

1. Please summarise the main aims, study design and endpoints of this trial?
2. What were your key findings?
3. What are the take-home messages?
4. How should this study influence further research into GP ablation for AF, and influence practice?

Editor: Jordan Rance
Videography: Oliver Miles

Recorded remotely from London, UK, 2021.

Radcliffe Group is a specialist provider of Cardiovascular, Renal and Metabolic (CVRM) content, The Radcliffe Group offers physicians access to content through a variety of media formats stemming from industry-leading peer-reviewed research journals, video interviews, live events and online medical courses.

Похожие видео

Добавлено: 55 год.
Добавил:
  © 2019-2021
  HRS 2021: GANGLIA-AF Trial - RusLar.Me